Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01665794 |
| Title | Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Chicago |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago Comprehensive Cancer Center | RECRUITING | Chicago | Illinois | 60637-1470 | United States | Details |
| University of Michigan Comprehensive Cancer Center | ACTIVE_NOT_RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
| Wayne State University - Karmonos Cancer Center | ACTIVE_NOT_RECRUITING | Detroit | Michigan | 48201 | United States | Details |
| Sarah Cannon Research Institute | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| University Health Network - Princess Margaret Cancer Center | ACTIVE_NOT_RECRUITING | Toronto | Ontario | MISG 2M9 | Canada | Details |